Amoy Diagnostics Co (SZSE:300685) COGS-to-Revenue : 0.14 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co COGS-to-Revenue?

Amoy Diagnostics Co's Cost of Goods Sold for the three months ended in Jun. 2024 was ¥44 Mil. Its Revenue for the three months ended in Jun. 2024 was ¥310 Mil.

Amoy Diagnostics Co's COGS to Revenue for the three months ended in Jun. 2024 was 0.14.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Amoy Diagnostics Co's Gross Margin % for the three months ended in Jun. 2024 was 85.68%.

Amoy Diagnostics Co COGS-to-Revenue Historical Data

The historical data trend for Amoy Diagnostics Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co COGS-to-Revenue Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.10

0.13

0.16

0.18

0.16

Amoy Diagnostics Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
COGS-to-Revenue	Get a 7-Day Free Trial															0.17	0.16	0.15	0.16	0.14

Amoy Diagnostics Co COGS-to-Revenue Calculation

Amoy Diagnostics Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	167.294	/	1043.507
	=	0.16

Amoy Diagnostics Co's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	44.364	/	309.729
	=	0.14

Amoy Diagnostics Co (SZSE:300685) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Amoy Diagnostics Co's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	44.364 / 309.729
	=	85.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Amoy Diagnostics Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co Headlines

No Headlines